Fibroids tend to grow in an estrogenic environment. When estrogen levels are low, either because of ovarian failure or a medically induced hypoestrogenic state, fibroid size is reduced and symptoms ...
Hologic HOLX continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--A new survey commissioned by Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, revealed a lack of awareness among U.S. women about uterine health, ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
In recent years, there has been an increasing focus on the contributory role of uterine fibroids to infertility. The prevalence of these tumors increases with age, which becomes significant as more ...
Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked the strongest growth in fiscal 2025, as the company had earlier anticipated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback